Creatine kinase — CK, or CPK on older reports — is an enzyme. It is not the supplement, it is not made from the supplement, and a high result is not a reading of how much creatine someone takes. It sits inside muscle, heart and brain cells and moves a phosphate group between phosphocreatine and ADP to rebuild ATP, which is why it carries creatine's name. When muscle cell membranes are stressed or damaged, some of it leaks into the blood, and that is what the test measures.
For anyone who lifts, that leak has an ordinary cause. Hard training, and unfamiliar eccentric work most of all, puts CK into the thousands in healthy volunteers. What follows is what the reference ranges were built on, how high exercise takes CK, when a high value becomes a medical question, and what creatine supplementation has been measured to do to it.
The short answer, in numbers
| Situation | Creatine kinase | Source |
|---|---|---|
| Typical laboratory reference range | about 0–200 IU/L | Moghadam-Kia et al., Cleve Clin J Med 2016 |
| Threshold for further evaluation, white women | 325 IU/L | same review, from Brewster et al. 2007 |
| Threshold for further evaluation, white men | 504 IU/L | same |
| Threshold for further evaluation, Black women | 621 IU/L | same |
| Threshold for further evaluation, Black men | 1,200 IU/L | same |
| After strenuous activity | up to ~30× the upper limit within 24 h, falling over 7 days | same review |
| 4 days after 50 maximal eccentric arm contractions (203 volunteers) | 111 above 2,000 U/L; 51 above 10,000 U/L | Clarkson et al., Med Sci Sports Exerc 2006 |
| Exertional rhabdomyolysis (diagnosis) | symptoms plus ≥5× the upper limit | Tietze and Borchers, Sports Health 2014 |
Units: IU/L and U/L are the same unit as laboratories report it. "Upper limit" means the top of the laboratory's printed range.
What CK is, and what it is not
Three forms of the enzyme exist. MedlinePlus's test page, last updated 2023-10-25, describes them: CK-MM comes mostly from skeletal muscle and rises with injury, disease, certain medicines or recent intense exercise; CK-MB points mostly to heart muscle; CK-BB mostly to the brain. A standard "total CK" lumps them together, and a separate isoenzyme test separates them when the source is in question.
The name causes two confusions. The first is with creatinine, the waste product creatine breaks down into, which the kidneys clear and which a kidney panel measures. The second is with creatine, the compound itself, which a routine blood test does not measure at all. The three are told apart, row by row, on what creatine means on bloodwork. The short version: a high CK says muscle cells have been leaking; it says nothing directly about the kidneys or about supplement intake.
The reference-range problem
A printed range is a statement about the people it was built on. The 2016 Cleveland Clinic Journal of Medicine review by Moghadam-Kia, Oddis and Aggarwal sets out the problem directly: most laboratories take the central 95% of results in white people and assume a bell-shaped distribution, which usually gives a range of about 0 to 200 IU/L. CK is not bell-shaped — its distribution is skewed towards higher values — and applying that range to nearly 1,000 healthy young people flagged 19% of the men and 5% of the women as abnormal.
The review recommends two corrections taken from the European Federation of Neurological Societies' guidance: use the 97.5th percentile rather than the 95th, and pursue further investigation only when CK is at least 1.5 times the upper limit. It then gives thresholds from Brewster and colleagues' 2007 general-population study, split by sex and race, because CK differs systematically between groups — the review names muscle mass and inherited differences in muscle membrane permeability as possible reasons:
- White women: 325 IU/L
- White men: 504 IU/L
- Black women: 621 IU/L
- Black men: 1,200 IU/L
A Black man with a CK of 900 IU/L is below the threshold the review gives for his group and above the printed range on most lab sheets. Trained people sit higher again: a 2018 study proposed a reference interval for professional footballers running to 1,971.7 U/L, set out on the bloodwork page.
How high training takes CK
The largest single dataset is Priscilla Clarkson's 2006 study at the University of Massachusetts. 203 volunteers each performed 50 maximal eccentric contractions of the elbow flexors — lowering a weight they could not lift, with one arm. Blood was drawn before and 4, 7 and 10 days after.
- CK was 6,420% above baseline on day 4, 2,100% on day 7 and 311% on day 10.
- 111 of the 203 had CK above 2,000 U/L on day 4, a level the authors note is used to diagnose myopathy such as statin myositis.
- 51 were above 10,000 U/L, a level used to diagnose rhabdomyolysis.
- No measure of kidney function changed — creatinine, blood urea nitrogen, phosphorus, potassium, osmolality and uric acid all stayed flat — and no participant had visible myoglobin in the urine or needed treatment.
That was one arm, once. The point the authors draw is that a CK number alone cannot separate a hard, unaccustomed session from a disease. The 2016 review generalises it: CK may rise to as much as 30 times the upper limit within 24 hours of strenuous activity and decline over about seven days, and the rise is greater in people who are untrained for that kind of work. The timing in Clarkson's eccentric model peaked later — day 4 was the first sample after exercise — which is typical of eccentric damage, where soreness and CK both lag.
The same review cites a Norwegian population study (the Tromsø Study, 2011): of people whose high CK was found incidentally, 70% had a normal value after three days of rest. Its recommended step for an asymptomatic high CK is to repeat the test after seven days without exercise.
When a high CK is a medical question
Rhabdomyolysis is the breakdown of muscle severe enough to release myoglobin and electrolytes in quantities that can injure the kidneys and the heart. In the exertional form, Tietze and Borchers' 2014 clinical review in Sports Health states the diagnostic rule plainly: muscle pain, tenderness, weakness and swelling following activity, together with CK at least five times the upper limit of normal. The number without the clinical picture is not the diagnosis — which is why Clarkson's 51 volunteers above 10,000 U/L, with no symptoms beyond soreness and normal kidney markers, were not treated as cases.
The same review describes urine that is occasionally darkened, "tea or cola coloured", from myoglobin, and notes that myoglobin clears from urine quickly enough that its absence does not rule the condition out. It lists heat, sickle cell trait, stimulants such as phentermine, infection and certain drugs among associated factors. Military clinical guidance on exertional rhabdomyolysis was updated in 2021 (Nye et al., Curr Sports Med Rep) and covers diagnosis, admission and return to duty.
Raised CK at rest, without recent training, has a long list of non-exercise causes. The 2016 review names medicines first: up to 5% of statin users develop CK elevation, typically 2 to 10 times the upper limit, which usually falls after the statin is stopped but can take weeks to months. Thyroid disease, other drugs and inherited muscle conditions follow. Sorting these out is a clinician's work-up, and the review's algorithm starts with the repeat test after rest.
None of this is advice for an individual result. A CK reading that stays high, rises, or arrives with weakness, swelling or dark urine is a question for a doctor, who has the rest of the panel and the history.
What creatine supplementation does to CK
A PubMed search run on 2026-10-20 for randomised controlled trials with creatine supplementation or creatine monohydrate and "creatine kinase" in the title or abstract returned 14 records. They do not point one way.
- Raised, within range. In a double-blind trial in 14 football players (7 creatine, 7 placebo) — 15 g a day for 7 days, then 3 g a day for 49 days during normal training — total CK activity rose significantly in the creatine group, and every blood and urine marker stayed within normal reference values. The authors read the rise as a possible effect on energy metabolism, not damage (Cancela et al., Br J Sports Med 2008).
- Lower after damaging exercise, sometimes. Recovery trials that put people through a damaging session mostly report CK the same or lower with creatine. A 2021 meta-analysis of 13 trials found it lower only at 48 hours, with no difference in strength or soreness; a second 2021 meta-analysis of 9 trials reported about 31 U/L lower overall with high heterogeneity; a 2022 meta-analysis of 23 studies found lower markers after a single bout but higher markers when the bout followed weeks of supplemented training. The three are compared on creatine for recovery.
- Unchanged. Several of the 14 records report no CK difference between groups.
What the trials do not show is creatine supplementation producing CK values in the thousands, or CK rises with kidney or muscle injury attributed to creatine. The supplement's kidney record is on creatine and kidneys, and its wider adverse-event file on creatine side effects. The observational papers that link high creatine kinase to blood pressure are about the enzyme, not the supplement; they are separated on creatine and blood pressure.
What is not established
- A CK threshold for "too much training". The studies describe how high CK goes and how it falls; none sets a number above which training itself is unsafe for a healthy person.
- Reference ranges for lifters. A footballer interval exists; no published interval was found for resistance-trained populations as a group.
- Whether creatine changes the CK response to a given session in practice. The meta-analyses disagree on direction, and CK is a marker of membrane leak, not of how fast strength comes back.
Sources
All opened 2026-10-20.
- Moghadam-Kia S, Oddis CV, Aggarwal R. "Approach to asymptomatic creatine kinase elevation." Cleve Clin J Med 2016;83(1):37–42. PMID 26760521 — full text via PMC4871266.
- Clarkson PM, Kearns AK, Rouzier P, Rubin R, Thompson PD. "Serum creatine kinase levels and renal function measures in exertional muscle damage." Med Sci Sports Exerc 2006;38(4):623–7. PMID 16679975
- Brewster LM et al. "Distribution of creatine kinase in the general population: implications for statin therapy." Am Heart J 2007;154(4):655–61. PMID 17892987 — thresholds as reported in the 2016 review.
- Lilleng H et al. "Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study." Neuromuscul Disord 2011;21(7):494–500. PMID 21592795 — as reported in the 2016 review.
- Tietze DC, Borchers J. "Exertional rhabdomyolysis in the athlete: a clinical review." Sports Health 2014;6(4):336–9. PMID 24982707
- Nye NS et al. "Clinical Practice Guidelines for Exertional Rhabdomyolysis: A Military Medicine Perspective." Curr Sports Med Rep 2021;20(3):169–78. PMID 33655999 — abstract.
- Cancela P et al. "Creatine supplementation does not affect clinical health markers in football players." Br J Sports Med 2008;42(9):731–5. PMID 18780799
- Northeast B, Clifford T. Int J Sport Nutr Exerc Metab 2021 PMID 33631721; Jiaming Y, Rahimi MH. J Food Biochem 2021 PMID 34472118; Doma K et al. Sports Med 2022 PMID 35218552.
- MedlinePlus, "Creatine Kinase (CK)" lab test page, last updated 2023-10-25. medlineplus.gov
- PubMed census: ("creatine supplementation" OR "creatine monohydrate") AND "creatine kinase", title/abstract, randomized controlled trial, 14 records, run 2026-10-20.